SuperworthMilestone Pharmaceuticals shares outstanding MIST
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 138.7M
- On a year earlier
- +108.9%
- more shares
Milestone Pharmaceuticals had 138.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 108.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 105.8M | +60% |
| FY2024 | 66.2M | +54% |
| FY2023 | 43.1M | +1% |
| FY2022 | 42.8M | +1% |
| FY2021 | 42.2M | +10% |
| FY2020 | 38.3M | +56% |
| FY2019 | 24.5M | +5446% |
| FY2018 | 441.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 138.7M | +109% | |
| Q1 FY26 | 130.3M | +97% | |
| Q4 FY25 | 105.8M | +60% | |
| Q3 FY25 | 96.5M | +46% | |
| Q2 FY25 | 66.4M | +0% | |
| Q1 FY25 | 66.3M | +32% | |
| Q4 FY24 | 66.2M | +54% | |
| Q3 FY24 | 66.2M | +54% | |
| Q2 FY24 | 66.2M | +54% | |
| Q1 FY24 | 50.2M | +17% | |
| Q4 FY23 | 43.1M | +1% | |
| Q3 FY23 | 43M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Milestone Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.